Literature DB >> 21749547

Immunological differences in women compared with men: overview and contributing factors.

Ghina Ghazeeri1, Lina Abdullah, Ossama Abbas.   

Abstract

CITATION: Ghazeeri G, Abdullah L, Abbas O. Immunological differences in women compared with men: overview and contributing factors. Am J Reprod Immunol 2011; 66: 163-169 Gender differences in the innate and adaptive immune systems have long been observed in humans. These immunological differences in immune function manifest as diverse susceptibilities to different types of infections and varied risks of developing autoimmune disorders and maybe even, cancers. Several factors contribute to the development of this immunological dimorphism including sex hormones, genetic makeup, environmental causes, and more recently microchimerism. Although the aim behind this sexual immune dimorphism is still unclear, it is tempting to believe that the higher risk of developing autoimmune diseases in women somehow serves the higher evolutionary goal of reproduction and creating new life.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Year:  2011        PMID: 21749547     DOI: 10.1111/j.1600-0897.2011.01052.x

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  27 in total

1.  Comprehensive Analysis of Individual Variation in the Urinary Proteome Revealed Significant Gender Differences.

Authors:  Chen Shao; Mindi Zhao; Xizhao Chen; Haidan Sun; Yehong Yang; Xiaoping Xiao; Zhengguang Guo; Xiaoyan Liu; Yang Lv; Xiangmei Chen; Wei Sun; Di Wu; Youhe Gao
Journal:  Mol Cell Proteomics       Date:  2019-03-20       Impact factor: 5.911

2.  Binding of estrogen receptors to switch sites and regulatory elements in the immunoglobulin heavy chain locus of activated B cells suggests a direct influence of estrogen on antibody expression.

Authors:  Bart G Jones; Rhiannon R Penkert; Beisi Xu; Yiping Fan; Geoff Neale; Patricia J Gearhart; Julia L Hurwitz
Journal:  Mol Immunol       Date:  2016-08-03       Impact factor: 4.407

3.  Predictors of immunotherapy-induced immune-related adverse events.

Authors:  A Kartolo; J Sattar; V Sahai; T Baetz; J M Lakoff
Journal:  Curr Oncol       Date:  2018-10-31       Impact factor: 3.677

4.  Sex differences in the relationship of IL-6 signaling to cancer cachexia progression.

Authors:  Kimbell L Hetzler; Justin P Hardee; Melissa J Puppa; Aditi A Narsale; Shuichi Sato; J Mark Davis; James A Carson
Journal:  Biochim Biophys Acta       Date:  2014-12-30

5.  Level of circulating steroid hormones in malaria and cutaneous leishmaniasis: a case control study.

Authors:  Farideh Esfandiari; Bahador Sarkari; Habibollah Turki; Nasir Arefkhah; Najme Shakouri
Journal:  J Parasit Dis       Date:  2018-11-20

6.  Polymorphisms within the human leucocyte antigen-E gene and their associations with susceptibility to rheumatoid arthritis as well as clinical outcome of anti-tumour necrosis factor therapy.

Authors:  M Iwaszko; J Świerkot; K Kolossa; S Jeka; P Wiland; K Bogunia-Kubik
Journal:  Clin Exp Immunol       Date:  2015-09-28       Impact factor: 4.330

7.  Endogenous hepatic glucocorticoid receptor signaling coordinates sex-biased inflammatory gene expression.

Authors:  Matthew A Quinn; John A Cidlowski
Journal:  FASEB J       Date:  2015-11-18       Impact factor: 5.191

8.  Gender differences in cancer susceptibility: an inadequately addressed issue.

Authors:  M Tevfik Dorak; Ebru Karpuzoglu
Journal:  Front Genet       Date:  2012-11-28       Impact factor: 4.599

9.  The phenotype of hormone-related allergic and autoimmune diseases in the skin: annular lesions that lateralize.

Authors:  Ramya Kollipara; Chetna Arora; Colleen Reisz
Journal:  J Allergy (Cairo)       Date:  2012-12-17

10.  Metabolomic profiles are gender, disease and time specific in the interleukin-10 gene-deficient mouse model of inflammatory bowel disease.

Authors:  Victor K Tso; Beate C Sydora; Rae R Foshaug; Thomas A Churchill; Jason Doyle; Carolyn M Slupsky; Richard N Fedorak
Journal:  PLoS One       Date:  2013-07-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.